$49.6 Million
TELA Bio, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$68.3 Million
Reneo
Reneo Pharmaceuticals
Confidentially Marketed Follow-On Offering
Active Bookrunner
$621.0 Million
Acelyrin
Acelyrin, Inc.
Initial Public Offering
Active Bookrunner
$100.0 Million
Protagonist
Protagonist Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
AspenAerogels
Aspen Aerogels, Inc.
At The Market Offering
Active Bookrunner
$65.0 Million
Redwood Trust
Preferred Stock
Active Bookrunner
$287.5 Million
Pliant Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
$110.5 Million
Paragon 28, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$125.0 Million
Fulcrum Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$258.8 Million
Replimune
Replimune Group, Inc.
Follow-On Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.